The 2025 Nobel Prize in Physiology or Medicine is awarded to Joel Habener, Svetlana Mojsov, and Jens Juul Holst for their discovery and development of GLP-1based therapeutics, which have revolutionized the treatment of diabetes and obesity worldwide. Well
Available both as an injectable and an oral medication, semaglutide offers flexibility for those in Lenexa aiming to improve their health
Chemical peels, laser treatments, Hydrafacial, and glutathione are commonly used for brighter and healthier-looking skin
Revolutionizing GLP-1 delivery with sublingual administration Recently, a new sublingual modality for GLP-1 receptor agonists (and also for insulins) delivery has been developed by the Dutch company SUBLIN BV, established in 2018 as a spin-out of the healthcare branch of NanoServe BV
Several factors may contribute to these cardiovascular outcomes
References: Almandoz, J